Back

LINE-1 ORF2p endonuclease activity links DNA damage signalling to enhancer associated chromatin remodeling

Kumar, A.; Parida, A. S.; Bhatoa, K.; Raghav, S.; Tiwari, B.

2026-04-22 cancer biology
10.64898/2026.04.20.719662 bioRxiv
Show abstract

Aberrant expression of Long Interspersed Element-1 (LINE-1/L1) retrotransposons is increasingly linked to genomic instability in cancer, particularly in the context of compromised p53 function. The endonuclease (EN) domain of the LINE-1 ORF2 protein (ORF2p) generates DNA strand breaks, yet its role in shaping downstream chromatin and transcriptional responses remains poorly defined. Here, we investigate the impact of ORF2p-EN activity on DNA damage response signalling and epigenomic remodeling in isogenic wild-type and p53-deficient A375 melanoma cells using a L1 expression system. ORF2p-EN expression induced activation of ATM dependent DNA damage signalling, as evidenced by increased {gamma}H2AX accumulation. This response was accompanied by altered levels of the DNA repair factor XRCC5, consistent with engagement of non-homologous end joining pathways. Notably, EN-associated DNA damage correlated with increased p300 activity and enhanced H3K27ac enrichment at regulatory regions, suggesting coupling between DNA damage signalling and chromatin acetylation. Pharmacological inhibition of ATM attenuated both {gamma}H2AX accumulation and H3K27ac levels, supporting a model in which chromatin remodeling occurs downstream of DNA damage signalling. Collectively, our findings position ORF2p endonuclease activity as an initiating source of DNA damage that is functionally linked to chromatin remodeling and transcriptional reprogramming, with p53 acting as a critical modulator of this axis. These results provide mechanistic insight into how LINE-1 activation may contribute to oncogenic gene expression programs in cancer.

Matching journals

The top 5 journals account for 50% of the predicted probability mass.

1
Molecular Cell
308 papers in training set
Top 0.7%
14.5%
2
Nature Communications
4913 papers in training set
Top 14%
12.2%
3
Cell Reports
1338 papers in training set
Top 3%
10.0%
4
Oncogene
76 papers in training set
Top 0.1%
10.0%
5
Nucleic Acids Research
1128 papers in training set
Top 3%
6.2%
50% of probability mass above
6
Cancer Research
116 papers in training set
Top 0.7%
3.9%
7
eLife
5422 papers in training set
Top 26%
3.5%
8
Proceedings of the National Academy of Sciences
2130 papers in training set
Top 23%
3.0%
9
PLOS Genetics
756 papers in training set
Top 7%
2.1%
10
Developmental Cell
168 papers in training set
Top 8%
1.9%
11
Molecular Cancer Research
42 papers in training set
Top 0.2%
1.9%
12
Genes & Development
90 papers in training set
Top 0.5%
1.6%
13
The EMBO Journal
267 papers in training set
Top 3%
1.3%
14
EMBO reports
136 papers in training set
Top 4%
1.3%
15
Blood
67 papers in training set
Top 1.0%
1.2%
16
Journal of Experimental Medicine
106 papers in training set
Top 3%
1.2%
17
Molecular Cancer
14 papers in training set
Top 0.6%
1.2%
18
Nature Cell Biology
99 papers in training set
Top 4%
0.9%
19
NAR Cancer
36 papers in training set
Top 0.1%
0.9%
20
Journal of Cell Biology
333 papers in training set
Top 4%
0.9%
21
EMBO Reports
88 papers in training set
Top 0.6%
0.8%
22
Nature Structural & Molecular Biology
218 papers in training set
Top 5%
0.7%
23
Cancer Discovery
61 papers in training set
Top 2%
0.7%
24
Cell Death & Differentiation
48 papers in training set
Top 0.8%
0.7%
25
Science Advances
1098 papers in training set
Top 32%
0.7%
26
Nature Genetics
240 papers in training set
Top 9%
0.6%
27
Scientific Reports
3102 papers in training set
Top 78%
0.6%
28
EMBO Molecular Medicine
85 papers in training set
Top 6%
0.6%